Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George W Booz

Showing results (1-10 of 181) with videos related to

Pageof 19
Sort By:
Congestive Heart Failure (Greenwich, Conn.)|March 30, 2007
PARP inhibitors and heart failure--translational medicine caught in the actGeorge W Booz
Journal of Cardiovascular Pharmacology|August 2, 2007
Devising new drugs for the treatment of hypertension--"novel drugs targeting hypertension: renin inhibitors and beyond"George W Booz
Journal of Cardiovascular Pharmacology|September 17, 2010
Novel drugs targeting hypertension revisitedGeorge W Booz
Free Radical Biology & Medicine|January 18, 2011
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stressGeorge W Booz
Hypertension (Dallas, Tex. : 1979)|May 1, 2004
Cardiac angiotensin AT2 receptor: what exactly does it do?George W Booz
Journal of Cardiovascular Pharmacology|December 13, 2023
Journal of Cardiovascular Pharmacology Welcomes New AssociatesGeorge W Booz
Hypertension (Dallas, Tex. : 1979)|July 7, 2005
Growing old, angiotensin II, cardiac hypertrophy, and death: making the connection with p66ShcGeorge W Booz
Journal of Cardiovascular Pharmacology|November 2, 2018
Seizing the Future: What's Next for the Journal of Cardiovascular Pharmacology?George W Booz
Hypertension (Dallas, Tex. : 1979)|February 16, 2005
Putting the brakes on cardiac hypertrophy: exploiting the NO-cGMP counter-regulatory systemGeorge W Booz
Hypertension (Dallas, Tex. : 1979)|June 1, 2006
Impact of T lymphocytes on cardiac remodeling in hypertension: more questions than answersGeorge W Booz
Pageof 19

Showing results (1-10 of 181) with videos related to

Sort By:
Pageof 19
Congestive Heart Failure (Greenwich, Conn.)|March 30, 2007
PARP inhibitors and heart failure--translational medicine caught in the actGeorge W Booz
Journal of Cardiovascular Pharmacology|August 2, 2007
Devising new drugs for the treatment of hypertension--"novel drugs targeting hypertension: renin inhibitors and beyond"George W Booz
Journal of Cardiovascular Pharmacology|September 17, 2010
Novel drugs targeting hypertension revisitedGeorge W Booz
Free Radical Biology & Medicine|January 18, 2011
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stressGeorge W Booz
Hypertension (Dallas, Tex. : 1979)|May 1, 2004
Cardiac angiotensin AT2 receptor: what exactly does it do?George W Booz
Journal of Cardiovascular Pharmacology|December 13, 2023
Journal of Cardiovascular Pharmacology Welcomes New AssociatesGeorge W Booz
Hypertension (Dallas, Tex. : 1979)|July 7, 2005
Growing old, angiotensin II, cardiac hypertrophy, and death: making the connection with p66ShcGeorge W Booz
Journal of Cardiovascular Pharmacology|November 2, 2018
Seizing the Future: What's Next for the Journal of Cardiovascular Pharmacology?George W Booz
Hypertension (Dallas, Tex. : 1979)|February 16, 2005
Putting the brakes on cardiac hypertrophy: exploiting the NO-cGMP counter-regulatory systemGeorge W Booz
Hypertension (Dallas, Tex. : 1979)|June 1, 2006
Impact of T lymphocytes on cardiac remodeling in hypertension: more questions than answersGeorge W Booz
Pageof 19